申请人:Kissei Pharmaceutical Co., Ltd.
公开号:US05294718A1
公开(公告)日:1994-03-15
Piperidino-3,4-dihydrocarbostyril compounds represented by the formula: ##STR1## wherein R.sup.1 represents a hydroxy group or an acyloxy group having 2 to 11 carbon atoms; one of R.sup.2 and R.sup.3 represents a nitro group, a cyano group, an alkoxycarbonyl group having 2 to 7 carbon atoms, an alkyl group having 1 to 4 carbon atoms, a haloalkyl group having 1 to 3 carbons atoms, or a halogen atom, and the other represents a hydrogen atom; and pharmaceutically acceptable salts thereof, exhibit platelet aggregation inhibiting activity and thus being useful as therapeutic agents for the prevention or treatment of cerebral ischemic disorders and arterial ischemic disorders.
Piperidino-3,4-二氢-碳基苯丙酰胺化合物的化学式为:##STR1##其中R.sup.1代表具有2至11个碳原子的羟基或酰氧基;R.sup.2和R.sup.3中的一个代表硝基、氰基、具有2至7个碳原子的烷氧羰基、具有1至4个碳原子的烷基、具有1至3个碳原子的卤代烷基或卤素原子,另一个代表氢原子;以及其药学上可接受的盐,表现出血小板聚集抑制活性,因此可用作预防或治疗脑缺血性疾病和动脉缺血性疾病的治疗剂。